Cambridge-based mental health technology provider Psyomics has appointed Dr Melinda Rees as its permanent chief executive and Dr Michelle Tempest as a non-executive director.

Rees becomes chief executive following an interim period in the post. She has had a 25-year clinical career as a consultant clinical psychologist in the NHS and held executive positions in global healthcare, digital solutions and private equity and venture capital-backed businesses.

Tempest has experience of psychiatry, healthcare innovation and strategy. She has been a partner at strategic consultancy Candesic since 2013 and has delivered projects for NHS trusts, community providers, the UK government and investors.

Rees said: “As CEO of Psyomics, I know that having Dr Michelle Tempest on the team marks a significant step in our commitment to enhancing mental health support for all, as we accelerate our work with younger generations, focusing on preventing mental health challenges in adulthood. With Dr Tempest’s global perspective, we are poised to make a significant impact to improving access to mental health.”

Tempest commented: “Mental health is a crucial aspect of healthcare and I am passionate about leveraging my experience in psychiatry to contribute to Psyomics’ innovative approach. My focus will be on ensuring that our solutions not only meet the needs of our customers, but also make a tangible difference in the lives of patients. Together, we can shape a future where mental health care is accessible, efficient, and profoundly effective.”